A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis
(Q28183038)
scientific article (publication date: December 2003)
scientific article (publication date: December 2003)
Language:
Current Data About
A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis